Blood Pressure & Cholesterol
Buy blood pressure and cholesterol management compounds in Canada! Telmisartan, Cardarine (GW501516), Rosuvastatin, Nebivolol, Omega-3 pharmaceutical grade and more, shipped domestically from within Canada. Every compound is third party tested with a certificate of analysis on file. Essential cardiovascular support compounds for anabolic research protocols and general cardiovascular health research.
Canada's most trusted domestic source for cardiovascular support research compounds. Blood pressure management, lipid optimisation, endurance enhancement, and cardioprotective agents. All sourced, tested, and dispatched same day from within Canada with no customs and no cross border delays.
![Clopidogrel 75mg - 30 Tablets [BLOOD PRESSURE]](https://www.canadasteroiddepot.is/wp-content/uploads/2026/03/CLOPIDOGREL-75-X-30-300x300.png "Clopidogrel 75mg - 30 Tablets [BLOOD PRESSURE] 9")
Explore related categories
Blood Pressure & Cholesterol Compounds in Canada | Cardiovascular Support for Anabolic Research
Cardiovascular parameter management is one of the most critical ancillary research areas in anabolic steroid and performance compound research. Exogenous androgens, particularly oral 17-alpha alkylated compounds, and non aromatizing androgens such as Trenbolone and Masteron, can adversely impact lipid profiles; raising LDL, reducing HDL, and elevating blood pressure through a combination of fluid retention, haematocrit elevation, and direct vascular effects. Canada Steroid Depot stocks the complete range of compounds used to manage blood pressure and lipid parameters throughout and following anabolic research protocols, as well as compounds researched for their direct cardiovascular and endurance enhancing properties.
Blood pressure management | ARBs and beta blockers
Angiotensin receptor blockers (ARBs) are the most widely researched antihypertensive compound class in anabolic research contexts due to their favorable side effect profile, renal protective properties, and additional metabolic benefits beyond blood pressure reduction. Telmisartan is the most studied ARB in this context; it is a potent, long acting ARB (half-life 24 hours, once daily dosing) that also acts as a partial PPAR gamma agonist, producing additional benefits including improved insulin sensitivity, lipid modulation, and potential anti proliferative effects. Nebivolol is a highly selective beta-1 blocker with vasodilatory properties via nitric oxide release, studied for blood pressure management with a superior side effect profile compared to older beta blockers particularly with respect to sexual function and exercise tolerance.
Lipid management | statins and fibrates
Anabolic androgenic steroids particularly oral 17-AA compounds and non aromatizing androgens can significantly alter lipid profiles, raising LDL cholesterol and triglycerides while reducing HDL cholesterol. Statins are the most effective pharmacological intervention for LDL reduction, working by inhibiting HMG CoA reductase. The rate limiting enzyme in cholesterol biosynthesis. Rosuvastatin (Crestor) is the most potent statin and the most commonly researched in anabolic contexts due to its high efficacy, minimal CYP450 metabolism (reducing interaction risk with other compounds), and favorable HDL raising properties compared to other statins. Omega-3 fatty acids at pharmacological doses (3–4g EPA+DHA daily) are researched for triglyceride reduction and HDL support as a complementary intervention.
Cardarine (GW501516) | endurance and lipid research
Cardarine (GW501516) is a PPARδ (Peroxisome Proliferator Activated Receptor delta) agonist originally developed by GlaxoSmithKline for cardiovascular disease and metabolic syndrome research. It is studied for its ability to dramatically increase fatty acid oxidation, improve endurance capacity, enhance lipid profiles (raising HDL, reducing LDL and triglycerides), and improve insulin sensitivity. In animal models, Cardarine produced profound endurance improvements and favourable lipid changes. Development was discontinued by GSK following carcinogenicity signals in long term rodent studies. Researchers should review the full safety literature before including Cardarine in any protocol.
Haematocrit management on anabolic protocols
Elevated haematocrit (polycythaemia) is one of the most commonly encountered cardiovascular parameters requiring management in testosterone and anabolic steroid research; particularly on long term TRT or high dose cycles. Elevated haematocrit increases blood viscosity, raising the risk of thrombotic events. The most researched interventions for haematocrit management include therapeutic phlebotomy (blood donation), adequate hydration, and in research contexts, the use of compounds that reduce erythropoiesis stimulation. Telmisartan's dual ARB and PPAR-gamma effects are studied for their potential haematocrit moderating properties alongside blood pressure management.
Frequently asked questions
CSD stocks Telmisartan, Nebivolol, Rosuvastatin, Cardarine (GW501516), pharmaceutical grade Omega-3, and more. Check the category page for current availability and stock status.
Telmisartan is preferred for several reasons: it has a 24 hour half-life allowing once daily dosing, it is the only ARB with significant PPAR gamma partial agonism producing additional metabolic benefits, it has strong renal protective properties relevant to long term anabolic research, and it has a highly favourable side effect profile with no impact on sexual function, exercise tolerance, or lipid parameters. Its dual cardiovascular and metabolic mechanism makes it the most versatile blood pressure compound for anabolic research contexts.
Rosuvastatin is the most commonly researched statin in anabolic contexts for several reasons: it is the most potent LDL reducing statin, it has minimal CYP3A4 metabolism reducing interaction risk with other compounds, it produces the most favourable HDL raising effect of all statins, and it does not cross the blood brain barrier. Avoiding the cognitive side effects reported with lipophilic statins. Typical research doses range from 5–20mg daily depending on the degree of lipid disruption.
Cardarine (GW501516) is a PPARδ agonist studied for endurance enhancement and lipid improvement. Development was halted by GlaxoSmithKline following carcinogenicity signals observed in long term rodent studies at high doses. The relevance of these findings to short term human research use remains debated. Researchers should thoroughly review the available safety literature including the rodent carcinogenicity data before incorporating Cardarine into any protocol. CSD stocks Cardarine for research purposes only.
Anabolic steroids impact cardiovascular parameters through multiple mechanisms. Oral 17-AA compounds are particularly hepatotoxic and adversely affect lipid profiles by reducing HDL and raising LDL. Non aromatizing androgens such as Trenbolone and Masteron have the most severe lipid impact. Testosterone raises haematocrit through erythropoiesis stimulation, increasing blood viscosity. Fluid retention from aromatizing androgens can elevate blood pressure. Managing these parameters with appropriate ancillary compounds throughout anabolic research protocols is strongly recommended.
All orders ship from within Canada via tracked Canada Post or courier. Packages are plain and discreet with no identifying product information on the exterior. Most orders arrive within 2–5 business days depending on your province. Express shipping is available at checkout. Orders over $250 qualify for free shipping Canada wide.